This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why You Should Hold on to Equifax (EFX) Stock For Now
by Zacks Equity Research
Equifax's (EFX) top line is showing a decent growth rate over the past few years. A debt-laden balance sheet remains a concern.
Here's Why You Should Hold on to Envestnet (ENV) Stock For Now
by Zacks Equity Research
Envestnet's (ENV) business model ensures solid asset-based and subscription-based recurring revenue generation capacity.
Here's Why You Should Buy FLEETCOR Technologies (FLT) Stock Now
by Zacks Equity Research
FLEETCOR's (FLT) top line continues to grow organically, driven by an increase in transaction volume and acquisitions.
Omnicom (OMC) to Buy Berlin-Based Advertising Agency, antoni
by Zacks Equity Research
The acquisition is aimed at placing antoni in a pivotal role in Omnicom's (OMC) partnership with Mercedes-Benz to develop Team X.
Omnicom (OMC) to Acquire German Public Relations Agency OSK
by Zacks Equity Research
OSK, which serves Mercedes-Benz, can play a vital role in Omnicom's (OMC) partnership with the automotive luxury brand to develop Team X.
Here's Why You Should Retain Broadridge (BR) in Your Portfolio
by Zacks Equity Research
Solid shareholder-friendly measures and strong business model boosts Broadridge (BR) stock.
Accenture (ACN), Salesforce Join Mastercard's Sustainability Aim
by Zacks Equity Research
The collaboration builds on Accenture (ACN) and Salesforce's ongoing partnership and aimed at enabling Mastercard accomplish its Science Based Target.
Reasons to Retain Trane Technologies (TT) Stock For Now
by Zacks Equity Research
Trane Technologies (TT) prioritizes improving its business operating system and innovation through transformation initiatives and investments.
Veritone (VERI) Announces Completion of PandoLogic Buyout
by Zacks Equity Research
The buyout is expected to help Veritone (VERI) accelerate its push into the human resources and talent acquisition market.
IQVIA (IQV) Announces Collaboration With NRx Pharmaceuticals
by Zacks Equity Research
IQVIA (IQV) and NRx are set to work closely to support activities essential for emergency use authorization of ZYESAMI.
6 Reasons to Add Robert Half (RHI) to Your Portfolio Now
by Shuvra Shankar Dey
Robert Half's (RHI) wholly-owned subsidiary, Protiviti, is strongly positioned in the market. It currently has a double-digit margin and is a solid revenue performer.
Here's Why Investors Should Buy TransUnion (TRU) Stock Now
by Zacks Equity Research
Strong business model and favorable socio-economic trends are aiding TransUnion (TRU).
Genpact (G) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
5 Reasons to Add Insperity Stock (NSP) to Your Portfolio Right Now
by Zacks Equity Research
Insperity's (NSP) business is currently benefiting from strength in the professional employer organization or the PEO industry.
6 Reasons to Add FTI Consulting (FCN) to Your Portfolio Now
by Zacks Equity Research
FTI Consulting's (FCN) international operations help expand its geographic footprint and contribute to top-line growth.
Zacks.com featured highlights include: Best Buy, Atlas Air Worldwide, Genpact, Arch Capital and Nutrien
by Zacks Equity Research
Zacks.com featured highlights include: Best Buy, Atlas Air Worldwide, Genpact, Arch Capital and Nutrien
5 Stocks With Solid Sales Growth Worth Betting on Right Now
by Swayta Shah
Sales growth is a vital indicator of any company's financial health. Let's check Best Buy (BBY), Atlas Air Worldwide (AAWW), Genpact (G), Arch Capital Group (ACGL) & Nutrien (NTR) as these are likely to witness strong top-line growth.
Here's Why You Should Hold on to Accenture (ACN) Stock Now
by Zacks Equity Research
Strategic acquisitions and a solid cash position boost Accenture (ACN). Yet, higher talent cost is a headwind.
Here's Why Investors Should Retain Verisk (VRSK) Stock For Now
by Zacks Equity Research
Verisk (VRSK) is continuing its investments in people, data sets, analytic solutions, technology and complementary businesses.
Genpact (G) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Genpact (G) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Solid Business Model Aids TransUnion (TRU), High Debt Hurts
by Zacks Equity Research
Strong business model and favorable socio-economic trends boost TransUnion (TRU) stock. However, high debt is a headwind.
Genpact (G) Beats on Q2 Earnings, Stock Up 2.2% on Strong View
by Zacks Equity Research
Genpact's (G) second-quarter 2021 earnings and revenues improve year over year.
G vs. PAYX: Which Stock Is the Better Value Option?
by Zacks Equity Research
G vs. PAYX: Which Stock Is the Better Value Option?
Genpact (G) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Genpact (G) delivered earnings and revenue surprises of 22.22% and 2.38%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Genpact (G) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Genpact (G) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.